Table 3 Summary of visual acuity stratified by time of infection and type of treatment
From: Bacterial endophthalmitis following anti-VEGF intravitreal injections: a retrospective case series
Worse Vision PPV (N = 8) | Injection (N = 5) | Better Vision PPV (N = 10) | Total (N = 23) | P | |
|---|---|---|---|---|---|
VA before infection - logMAR‡ | 0.395 | ||||
Mean ± SD | 1.43 ± 0.96 | 1.26 ± 0.83 | 0.92 ± 0.53 | 1.15 ± 0.74 | |
Median (Range) | 1.75 (0.20 to 2.30) | 1.30 (0.30 to 2.30) | 0.90 (0.20 to 2.00) | 1.00 (0.20 to 2.30) | |
VA right before treatment - logMAR‡ | 0.002* | ||||
Mean ± SD | 2.80 ± 0.00 | 2.12 ± 0.30 | 1.79 ± 0.21 | 2.14 ± 0.75 | |
Median (Range) | 2.80 (2.80 to 2.80) | 2.00 (1.50 to 2.80) | 2.15 (0.50 to 2.30) | 2.30 (0.50 to 2.80) | |
VA after 1 year - logMAR‡ | 0.001* | ||||
Mean ± SD | 2.42 ± 0.30 | 1.56 ± 0.39 | 0.96 ± 0.14 | 1.56 ± 0.93 | |
Median (Range) | 2.90 (0.90 to 3.00) | 1.50 (0.80 to 3.00) | 0.90 (0.50 to 2.00) | 1.00 (0.50 to 3.00) |